Navigation Links
Celator(R) Pharmaceuticals Announces Appointment of Scott Jackson as CEO
Date:5/9/2008

PRINCETON, N.J., May 9 /PRNewswire/ -- Celator Pharmaceuticals today announced that Scott Jackson has been appointed Chief Executive Officer. Mr. Jackson joined Celator in October 2007 as Head of Commercial Development.

"We are delighted to have Scott as the new CEO. He brings more than 20 years of pharmaceutical experience, including 10 years of specialty pharmaceutical experience primarily in oncology," said Dr. Joseph Mollica, Chairman of Celator's Board of Directors. "His senior management experience and commercial and clinical development knowledge will be extremely valuable to the organization as the company moves forward."

Mr. Jackson has extensive experience in the pharmaceutical and biotechnology industry and has held positions of increasing responsibility in sales, marketing, and commercial development at Eli Lilly & Co., SmithKline Beecham, ImClone Systems Inc., Centocor (Johnson & Johnson), Eximias Pharmaceuticals and YM BioSciences. Mr. Jackson holds a B.S. in Pharmacy from the Philadelphia College of Pharmacy and Science and an M.B.A. from the University of Notre Dame. Mr. Jackson succeeds Dr. Andrew Janoff.

"I'm very excited about the future for Celator Pharmaceuticals," said Mr. Jackson. "We have an entrepreneurial spirit and commitment at the company and I look forward to contributing to the company's growth and success."

"Celator has two promising products in clinical development based on the company's proprietary drug ratio technology platform, CombiPlex (TM). Results from a Phase 2 study of CPX-1 (a liposomal formulation of irinotecan:floxuridine) in patients with advanced colorectal cancer will be reported later this year at major medical conferences. Results from a Phase 1 study with CPX-351 (a liposomal formulation of cytarabine:daunorubicin) in patients with advanced leukemias will be submitted to a conference before the end of the year," said Mr. Jackson. "In addition, Celator's CombiPlex (TM) technology pl
'/>"/>

SOURCE Celator Pharmaceuticals
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Celator(R) Pharmaceuticals Study Shows CPX-571 Maintains Synergistic Ratio of Irinotecan and Cisplatin to Improve Anti-tumor Activity
2. Celator(R) Pharmaceuticals to Present at 10th Annual BIO CEO and Investor Conference
3. Vion Pharmaceuticals Pays Interest on 7.75% Convertible Senior Notes
4. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
5. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
6. XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007
7. Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results
8. Nabi Biopharmaceuticals to Present at Upcoming Industry Conferences
9. Anadys Pharmaceuticals Appoints Steve Worland, Ph.D. as President and Chief Executive Officer
10. Poniard Pharmaceuticals Announces Participation in Upcoming Conferences
11. NovaQuest Advances Virtual Development Model With Strategic Investment in TOPIGEN Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/12/2008)...y 12 /- TorreyPines,Therape...the company will,conduct a conference call and aud... Eastern Time (ET), in conjunction with the releas...nded March 31, 2008. TorreyPines,anticipates relea...day, May,13, 2008., To participate in this confer...
(Date:5/12/2008)...May 12 /- Nektar,Therapeuti...prietary,PEGylation technology is used in the nove...based erythropoiesis-stimulating agent that is und...ment Center, Inc. and,Affymax. Data were presented...ess in Stockholm, Sweden, which showed that Hemati...
(Date:5/12/2008)... 12 /- Covance Inc. (NYSE:,....W. Baird 2008 Growth,Stock Conference on Tuesday,... a live webcast of the presentation at http://www...ny necessary software, please log on 10 minutes,ea...w Jersey, is one of the,world,s largest and most c...
(Date:5/12/2008)...12 /- Synvista Therapeutics...ommercial focus with the,appointment of David C. T...,newly created position. Beginning today, Mr. Tant...ting commercialization of the Company,s,haptoglobi...nch of this,product in mid- 2009., Mr. Tantillo b...
Breaking Biology Technology:TorreyPines Therapeutics to Host First Quarter 2008 Results Conference Call and Webcast 2Nektar's PEGylation Technology Enables Peptide Mimetic, Highlighted by Data Presented at 45th ERA-EDTA Congress 2Nektar's PEGylation Technology Enables Peptide Mimetic, Highlighted by Data Presented at 45th ERA-EDTA Congress 3Synvista Therapeutics Increases Commercial Focus by Appointing David C. Tantillo Senior Director of Marketing and Sales 2Synvista Therapeutics Increases Commercial Focus by Appointing David C. Tantillo Senior Director of Marketing and Sales 3Synvista Therapeutics Increases Commercial Focus by Appointing David C. Tantillo Senior Director of Marketing and Sales 4
... get an idea of the intricacy possible in machinin...ng: using electro-discharge machining, or EDM, you...ll the metal under the image of Roosevelt, and lea... thin as foil. , ,Its an impressive example used b...wa Valley Technical Colleges glass and steel Manu...
...LWAUKEE Dean Amhaus, the image-conscious presiden...title of that 1970s sitcom featuring two ditzy wom...the show (lets call it L and S, in respect to Amha...ith others to do the same. , ,Frank Langley of Pe...ts Scandinavian owners to consolidate North Americ...
...DISON, Wis. - The Wisconsin Alumni Research Found...with Mentor Corporation a California-based public...r the exclusive manufacturing and marketing rights...eloped at the University of Wisconsin-Madison. In ...of Botulinum toxin products in addition to cash pa...
...Editors Note: Wisconsins Department of Workforce...strengthening the states workforce. The department...nd jobs, increase wages, address workforce shortag...ces to Wisconsin workers. Secretary Roberta Gassma...twork talks about how DWD is investing in people a...
Other Biology Technology:Powerful, Intricate Technology Taught in CVTCs New Tool and Die Program 2Powerful, Intricate Technology Taught in CVTCs New Tool and Die Program 3From Rustbelt to Techtown: Milwaukee is Building a New Image and a New Economic Reality. 2From Rustbelt to Techtown: Milwaukee is Building a New Image and a New Economic Reality. 3Mentor Licenses Botulinum From WARF and Plans Wisconsin Manufacturing Facility 2WTN Interview: Roberta Gassman 2WTN Interview: Roberta Gassman 3
(Date:5/12/2008)...s today released a 20-year study showing that envi...ositive effect on reducing overall contaminant lev...port points to continuing concerns with elevated l...r urban and industrial areas of the coasts. , ... DDT, and industrial chemicals, such as PCBs, show...
(Date:5/11/2008)...t flies eat like horses. Hatching inside over-ripe...he sugar-rich environment until nature sends them ...eave the fruit, wander off and burrow into the ear...y then can the larvae grow and hatch into flies th...a team of researchers from the University of Georg...
(Date:5/9/2008)...lif., May 7 /PRNewswire-FirstCall/ -- Sangamo BioS...t Edward Lanphier, Sangamo,s,president and CEO, wi...ZFP,Therapeutic development programs and an overvi... (ET) on Tuesday, May 13, 2008 at the Bank of Amer...entation will be webcast live and may be accessed ...
(Date:5/9/2008)...hydrology is more important for predicting biodive... 8th issue of the journal Nature challenges curren...nues for predicting how climate change or human ac...he article, an international group of researchers ... in a river system can be accurately predicted wit...
Breaking Biology News(10 mins):NOAA reports coastal waters show decline in contaminants 2NOAA reports coastal waters show decline in contaminants 3Fruit fly avoidance mechanism could lead to new ways to control pain in humans 2Sangamo BioSciences to Present at the Bank of America 2008 Healthcare Conference 2Biodiversity -- it's in the water 2EDYS 28R 29 Slow Churned 28R 29 and Stop 26 Shop Stores Announce Scoop Day With Sweet Deals to Support the Fight Against Childhood Cancer 17514 1EDYS 28R 29 Slow Churned 28R 29 and Stop 26 Shop Stores Announce Scoop Day With Sweet Deals to Support the Fight Against Childhood Cancer 17514 2Schering Plough Reports Financial Results for First Quarter of 2008 4796 1Schering Plough Reports Financial Results for First Quarter of 2008 4796 2Schering Plough Reports Financial Results for First Quarter of 2008 4796 3Schering Plough Reports Financial Results for First Quarter of 2008 4796 4Schering Plough Reports Financial Results for First Quarter of 2008 4796 5Schering Plough Reports Financial Results for First Quarter of 2008 4796 6Schering Plough Reports Financial Results for First Quarter of 2008 4796 7Schering Plough Reports Financial Results for First Quarter of 2008 4796 8Schering Plough Reports Financial Results for First Quarter of 2008 4796 9Schering Plough Reports Financial Results for First Quarter of 2008 4796 10Schering Plough Reports Financial Results for First Quarter of 2008 4796 11Schering Plough Reports Financial Results for First Quarter of 2008 4796 12Schering Plough Reports Financial Results for First Quarter of 2008 4796 13Schering Plough Reports Financial Results for First Quarter of 2008 4796 14Schering Plough Reports Financial Results for First Quarter of 2008 4796 15Schering Plough Reports Financial Results for First Quarter of 2008 4796 16Schering Plough Reports Financial Results for First Quarter of 2008 4796 17Schering Plough Reports Financial Results for First Quarter of 2008 4796 18Schering Plough Reports Financial Results for First Quarter of 2008 4796 19The Greening of St Anthonys 17512 1The Greening of St Anthonys 17512 2Cord Blood America in Top 20 in Los Angeles Area Biotech Biomed Companies 4794 1Cord Blood America in Top 20 in Los Angeles Area Biotech Biomed Companies 4794 2
...f eight hospitals in Peru has shown that opening w...uble that of mechanically ventilated negative-pres... and doors closed. , The researchers, led by Rod ... airflow in 70 naturally ventilated clinical rooms...spiratory wards, general medical wards, outpatient...
...ed by scientists from the University of North Caro...r mechanism involved in the development of schizop... of adults who had been diagnosed with schizophren...ene-regulating molecules called microRNAs were low...o were free of psychiatric illness. , "In many ...
...euroscience Microarray Consortium today announced ...the Affymetrix and Illumina platforms to its list ...or at UCLA, says that "adding ultra-high throughpu...ators across the world keeps the Consortium curren..., The Consortium is comprised of four nationally r...
...omes to some of today’s health issues, 100 percent...ctors related to certain diseases. , This conclu... question traditional thinking that 100 percent ju... for both cancer and cardiovascular disease than w...rable in their ability to reduce risk compared to ...
Other Biology News:Brain tissue reveals possible genetic trigger for schizophrenia 2NIH neuroscience microarray consortium launches high-throughput genotyping services 2100 percent juices found as beneficial to health as fruits and vegetables 2
Experion HighSens chips are the microfluidic chips used to perform high-sensitivity RNA analysis (picogram levels) with the Experion automated electrophoresis system. Each chip has the capacity to ru
Silver Stain Kit from Bio-Rad
SILVER SEQUENCE Staining Reagents from Promega
Mouse Complement from Equitech-Bio
Biology Products: